141 related articles for article (PubMed ID: 24867287)
41. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
[TBL] [Abstract][Full Text] [Related]
42. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
[TBL] [Abstract][Full Text] [Related]
43. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.
López C; Kleinheinz K; Aukema SM; Rohde M; Bernhart SH; Hübschmann D; Wagener R; Toprak UH; Raimondi F; Kreuz M; Waszak SM; Huang Z; Sieverling L; Paramasivam N; Seufert J; Sungalee S; Russell RB; Bausinger J; Kretzmer H; Ammerpohl O; Bergmann AK; Binder H; Borkhardt A; Brors B; Claviez A; Doose G; Feuerbach L; Haake A; Hansmann ML; Hoell J; Hummel M; Korbel JO; Lawerenz C; Lenze D; Radlwimmer B; Richter J; Rosenstiel P; Rosenwald A; Schilhabel MB; Stein H; Stilgenbauer S; Stadler PF; Szczepanowski M; Weniger MA; Zapatka M; Eils R; Lichter P; Loeffler M; Möller P; Trümper L; Klapper W; ; Hoffmann S; Küppers R; Burkhardt B; Schlesner M; Siebert R
Nat Commun; 2019 Mar; 10(1):1459. PubMed ID: 30926794
[TBL] [Abstract][Full Text] [Related]
44. [Genetic analysis of two cases with MYC "negative" Burkitt lymphoma].
Lyu R; Zheng Y; An G; Li C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Nov; 40(11):1340-1344. PubMed ID: 37906138
[TBL] [Abstract][Full Text] [Related]
45. Mosaic chromosomal alterations in peripheral blood leukocytes of children in sub-Saharan Africa.
Zhou W; Fischer A; Ogwang MD; Luo W; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Ayers LW; Bhatia K; Goedert JJ; Gouveia MH; Cole N; Hicks B; Jones K; Hummel M; Schlesner M; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Glaser S; Kretzmer H; Manning M; Hutchinson A; Hsing AW; Tettey Y; Adjei AA; Chanock SJ; Siebert R; Yeager M; Prokunina-Olsson L; Machiela MJ; Mbulaiteye SM
Nat Commun; 2023 Dec; 14(1):8081. PubMed ID: 38057307
[TBL] [Abstract][Full Text] [Related]
46. Burkitt lymphoma in adults.
Perkins AS; Friedberg JW
Hematology Am Soc Hematol Educ Program; 2008; ():341-8. PubMed ID: 19074108
[TBL] [Abstract][Full Text] [Related]
47. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression.
Schiffman JD; Lorimer PD; Rodic V; Jahromi MS; Downie JM; Bayerl MG; Sanmann JN; Althof PA; Sanger WG; Barnette P; Perkins SL; Miles RR
Br J Haematol; 2011 Nov; 155(4):477-86. PubMed ID: 21981616
[TBL] [Abstract][Full Text] [Related]
48. Genetic differences between paediatric and adult Burkitt lymphomas.
Havelange V; Pepermans X; Ameye G; Théate I; Callet-Bauchu E; Barin C; Penther D; Lippert E; Michaux L; Mugneret F; Dastugue N; Raphaël M; Vikkula M; Poirel HA
Br J Haematol; 2016 Apr; 173(1):137-44. PubMed ID: 26887776
[TBL] [Abstract][Full Text] [Related]
49. Update on Burkitt Lymphoma.
Dunleavy K; Little RF; Wilson WH
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1333-1343. PubMed ID: 27888884
[TBL] [Abstract][Full Text] [Related]
50. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.
Dzikiewicz-Krawczyk A; Kok K; Slezak-Prochazka I; Robertus JL; Bruining J; Tayari MM; Rutgers B; de Jong D; Koerts J; Seitz A; Li J; Tillema B; Guikema JE; Nolte IM; Diepstra A; Visser L; Kluiver J; van den Berg A
Leukemia; 2017 Jun; 31(6):1470-1473. PubMed ID: 28331227
[No Abstract] [Full Text] [Related]
51. Cryptic insertion of
Wagener R; Bens S; Toprak UH; Seufert J; López C; Scholz I; Herbrueggen H; Oschlies I; Stilgenbauer S; Schlesner M; Klapper W; Burkhardt B; Siebert R
Haematologica; 2020 Apr; 105(4):e202-e205. PubMed ID: 31073073
[No Abstract] [Full Text] [Related]
52. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.
Giulino-Roth L; Wang K; MacDonald TY; Mathew S; Tam Y; Cronin MT; Palmer G; Lucena-Silva N; Pedrosa F; Pedrosa M; Teruya-Feldstein J; Bhagat G; Alobeid B; Leoncini L; Bellan C; Rogena E; Pinkney KA; Rubin MA; Ribeiro RC; Yelensky R; Tam W; Stephens PJ; Cesarman E
Blood; 2012 Dec; 120(26):5181-4. PubMed ID: 23091298
[TBL] [Abstract][Full Text] [Related]
53. The whole-genome landscape of Burkitt lymphoma subtypes.
Panea RI; Love CL; Shingleton JR; Reddy A; Bailey JA; Moormann AM; Otieno JA; Ong'echa JM; Oduor CI; Schroeder KMS; Masalu N; Chao NJ; Agajanian M; Major MB; Fedoriw Y; Richards KL; Rymkiewicz G; Miles RR; Alobeid B; Bhagat G; Flowers CR; Ondrejka SL; Hsi ED; Choi WWL; Au-Yeung RKH; Hartmann W; Lenz G; Meyerson H; Lin YY; Zhuang Y; Luftig MA; Waldrop A; Dave T; Thakkar D; Sahay H; Li G; Palus BC; Seshadri V; Kim SY; Gascoyne RD; Levy S; Mukhopadyay M; Dunson DB; Dave SS
Blood; 2019 Nov; 134(19):1598-1607. PubMed ID: 31558468
[TBL] [Abstract][Full Text] [Related]
54. Targeted deep next generation sequencing identifies potential somatic and germline variants for predisposition to familial Burkitt lymphoma.
Okabe M; Morishita T; Yasuda T; Sakaguchi H; Sanada M; Kataoka K; Ogawa S; Shiraishi Y; Ichiki T; Kawaguchi Y; Ohbiki M; Matsumoto R; Osaki M; Goto T; Ozawa Y; Miyamura K
Eur J Haematol; 2021 Jul; 107(1):166-169. PubMed ID: 33772882
[No Abstract] [Full Text] [Related]
55. Age-related heterogeneity of Burkitt lymphoma: response to Mbulaiteye and Anderson.
Poirel HA; Vikkula M
Br J Haematol; 2018 Jan; 180(1):155-156. PubMed ID: 27612331
[No Abstract] [Full Text] [Related]
56. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.
Wever CM; Geoffrion D; Grande BM; Yu S; Alcaide M; Lemaire M; Riazalhosseini Y; Hébert J; Gavino C; Vinh DC; Petrogiannis-Haliotis T; Dmitrienko S; Mann KK; Morin RD; Johnson NA
Leuk Lymphoma; 2018 Sep; 59(9):2159-2174. PubMed ID: 29295643
[TBL] [Abstract][Full Text] [Related]
57. Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation.
Atallah-Yunes SA; Habermann TM; Khurana A
Br J Haematol; 2024 Jun; 204(6):2165-2172. PubMed ID: 38577716
[TBL] [Abstract][Full Text] [Related]
58. Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma.
Reutter K; Sandmann S; Rohde J; Müller S; Wöste M; Khanam T; Michgehl U; Klapper W; Wößmann W; Seggewiß J; Lenz G; Dugas M; Burkhardt B
Leukemia; 2021 Feb; 35(2):639-643. PubMed ID: 32404974
[No Abstract] [Full Text] [Related]
59. Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma.
Kim M; Hwang HS; Yoon DH; Chun SM; Go H
Haematologica; 2022 Aug; 107(8):1999-2003. PubMed ID: 35354255
[No Abstract] [Full Text] [Related]
60. Message of myc in context.
Robertson M
Nature; 1984 Jun 14-20; 309(5969):585-7. PubMed ID: 6728018
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
